Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Probiotics on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Therapy in Patients With Obesity: A Randomized, Double-Blind, Controlled Trial

NCT07847593 is registered in ClinicalTrials.gov with Nordic Biotic Sp. z o.o. as lead sponsor.

NCT NCT07847593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07847593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Probiotics on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Therapy in Patients With Obesity: A Randomized, Double-Blind, Controlled Trial
Lead sponsor
Nordic Biotic Sp. z o.o.
Phase
Not applicable
Overall status
Completed
Start date
July 9, 2025
Completion date
July 15, 2026
Enrollment
102 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, glp-1 receptor agonist treatment, obesity (disorder), probiotic intervention